Controversy over rBST Use

The controversy over recombinant bovine somatotropin (rBST) involves its use to boost milk production in dairy cows. Proponents say it increases efficiency and farmer income. Critics raise concerns about animal welfare, suggesting rBST can lead to health problems like lameness and mastitis. There are also worries about potential impacts on human health, though scientific consensus finds no proven risk. Additionally, consumer and advocacy groups argue that using rBST contradicts natural dairy practices and transparency. As a result, some countries have banned or restricted its use, and many consumers prefer dairy products labeled as rBST-free.